https://pgtmsite.files.wordpress.com/2024/01/re_antipd1-et-msi-h-dmmr_20210629_final.pdf 2021 Canada drug information Treat During Treatment No Treatment for Diabetes Immune Microsatellite Instability Treatment Cell Cycle Checkpoint Biomaterial Treatment GDC Treatment Frequency Terminology Use neoplasms Mismatch Repair Protein Deficiency Mycobacterium simiae Measurement On Treatment Treatment Epoch Therapy Object Treatment Study Immune Checkpoint Inhibitors AML Myeloid Sarcoma Involvement Table Tumor Tissue Origin
--- https://pgtmsite.files.wordpress.com/2024/01/mic_msi-h_20210329_final-1.pdf 2021 Canada drug information Microsatellite Instability Treatment Therapy Object Treat Biomaterial Treatment Treatment Study During Treatment Mismatch Repair Protein Deficiency GDC Treatment Frequency Terminology Regulatory Report Clinical Testing Repair AML Myeloid Sarcoma Involvement Table microsatellite instability albumin/globulin ratio Device System Mycobacterium simiae Measurement Ratio Intervention Model evaluation studies as topic No Treatment for Diabetes Immune evaluation report On Treatment neoplasms Treatment Epoch Tumor Tissue Origin Clinical Evaluation Cell Cycle Checkpoint matched-pair analysis symptom assessment Drug Delivery System Category No Spacing Errors
Automatic exact mappings (from CISMeF team)